Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIMS Communications,Inc. (SISCD) -- Ignore unavailable to you. Want to Upgrade?

To: KZAP who wrote (6)	2/28/1998 11:07:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 40

KZAP, I read the news release about M3 being an investor and then recommending SISCD. Do you have a link for M3 website as I have questions about their numbers? The recent reverse split is the second in two years....the prior one was a 10 for 1 in 96. Did you read the 10q? Lower earnings were due to termination of Alamo Rent a Car deal. I didn't see where management negotiated capital improvements of 4.5 mil. Where can I find that? Some more questions. Hope that you don't mind if I ask them all at once: Can you explain to me what the symbol changes mean? The stock has gone from SIMSE to SIMS to SISCD to SIMSC to SISCD. The four founders recently resigned. Are they selling their shares? Why did they resign? Is there a lawsuit or lawsuits pending regarding the IPO? TIA and here's the M3 news release: DALLAS (Feb. 12) BUSINESS WIRE -Feb. 12, 1998--M3, a Dallas based venture capital and institutional research firm, has made an equity investment and has initiated research coverage on Sims Communications, Inc. (NASDAQ:SIMSC). Mike Pickens, president of M3, said, "We have looked at Sims and are impressed with the company's ability to develop proprietary ATM P.O.S. terminals which are also used for verification and authorization of a patient's health care provider coverage. We believe that Sims has the only cost effective automated verification and authorization system currently available to health care providers. -0- jm/bos nmb/db/ny CONTACT: Martin E. Janis & Company, Inc., Chicago Bev Jedynak, 312/943-1100